SCHEMBL5264030

SCHEMBL5264030

CCOC(=O)OC1CCN(c2ncnc(Nc3ccc(C4CCCCC4)cc3)c2[N+](=O)[O-])CC1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388692 0.89 GPR119 (0.76) GPR119
SCHEMBL5260172 0.89 GPR119 (0.65) GPR119
SCHEMBL5264940 0.88 GPR119 (0.64) GPR119
SCHEMBL5260975 0.87 GPR119 (0.80) GPR119
SCHEMBL5263920 0.86 GPR119 (0.62) GPR119
SCHEMBL5260768 0.86 GPR119 (0.62) GPR119
SCHEMBL5259856 0.85 GPR119 (0.61) GPR119
SCHEMBL5262527 0.85 GPR119 (0.61) GPR119
SCHEMBL5261927 0.85 GPR119 (0.60) GPR119
SCHEMBL5262824 0.85 GPR119 (0.60) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599468-B1 1,2,3-TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO SUCH AS DIABETES AND HYPERGLYCEMIA ARENA PHARM INC (US) 2007-10-03 EP claimed